NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

Search

Coloplast A-S (Class B)

Fechado

430 -1.26

Visão Geral

Variação de preço das ações

24h

Atual

Mín

428.2

Máximo

430.6

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.382

57.05

EPS

6.32

Rendimento de Dividendos

5.47

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.47%

2.52%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-21B

97B

Abertura anterior

431.26

Fecho anterior

430

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de mar. de 2026, 17:33 UTC

Notícias Principais

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27 de mar. de 2026, 17:00 UTC

Notícias Principais

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27 de mar. de 2026, 16:03 UTC

Notícias Principais

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29 de mar. de 2026, 23:47 UTC

Conversa de Mercado
Notícias Principais

Gold Falls Amid Rising Inflation Fears -- Market Talk

29 de mar. de 2026, 23:46 UTC

Conversa de Mercado
Notícias Principais

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29 de mar. de 2026, 23:35 UTC

Conversa de Mercado
Notícias Principais

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29 de mar. de 2026, 23:23 UTC

Conversa de Mercado

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29 de mar. de 2026, 22:34 UTC

Conversa de Mercado

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29 de mar. de 2026, 22:09 UTC

Conversa de Mercado

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29 de mar. de 2026, 21:06 UTC

Conversa de Mercado
Notícias Principais

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29 de mar. de 2026, 21:03 UTC

Conversa de Mercado

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29 de mar. de 2026, 21:01 UTC

Conversa de Mercado
Notícias Principais

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29 de mar. de 2026, 09:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28 de mar. de 2026, 08:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

27 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

27 de mar. de 2026, 19:16 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27 de mar. de 2026, 19:07 UTC

Conversa de Mercado

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27 de mar. de 2026, 19:04 UTC

Conversa de Mercado

Gold Rises But Can't Finish the Week Positive -- Market Talk

27 de mar. de 2026, 19:03 UTC

Conversa de Mercado
Notícias Principais

Global Forex and Fixed Income Roundup: Market Talk

27 de mar. de 2026, 19:02 UTC

Conversa de Mercado
Notícias Principais

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27 de mar. de 2026, 18:12 UTC

Conversa de Mercado

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27 de mar. de 2026, 17:36 UTC

Notícias Principais

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27 de mar. de 2026, 17:34 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27 de mar. de 2026, 17:29 UTC

Conversa de Mercado

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27 de mar. de 2026, 16:38 UTC

Conversa de Mercado

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27 de mar. de 2026, 16:32 UTC

Conversa de Mercado
Notícias Principais

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27 de mar. de 2026, 16:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

27 de mar. de 2026, 15:43 UTC

Conversa de Mercado
Notícias Principais

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27 de mar. de 2026, 15:25 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 de mar. de 2026, 15:25 UTC

Conversa de Mercado

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat